"A well established and experienced community based, non-profit, medical research centre that conducts relevant, ethical and beneficial research, across a broad spectrum of diseases, including HIV and TB."

During the past decade, Setshaba Research Centre conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 7 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 5 clinical trials were completed. i.e. 22.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Setshaba Research Centre" #1 sponsor was "Janssen Vaccines & Prevention B.V." with 5 trials, followed by "FHI 360" with 2 trials sponsored, "Global Alliance for TB Drug Development" with 2 trials sponsored, "HIV Vaccine Trials Network" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Setshaba Research Centre" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "Setshaba Research Centre" with 3 trials as a collaborator, "Bill and Melinda Gates Foundation" with 2 trials as a collaborator, "Bio Analytical Research Corporation" with 2 trials as a collaborator and "BioVac" with 2 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Setshaba Research Centre" are "HIV Infections" (5 trials), "Tuberculosis" (5 trials), "COVID-19" (4 trials), "SARS-CoV-2" (3 trials) and "HIV Prevention" (2 trials). Many other conditions were trialed in "Setshaba Research Centre" in a lesser frequency.

Most popular intervention types in "Setshaba Research Centre" are "Biological" (17 trials), "Drug" (12 trials), "Other" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Ad26.COV2.S" (3 trials), "Baloxavir Marboxil" (2 trials), "C-Tb" (2 trials) and "Moxifloxacin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Setshaba Research Centre" are 24 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Setshaba Research Centre". 1 are not yet recruiting, 9 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Setshaba Research Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Setshaba Research Centre, 4 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".